---
layout: post
title: "【图解年报】新天药业：2021年归母净利润同比增长35.8%，约为1亿元"
date: 2022-03-24 19:37:50 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>新天药业于2022年3月25日披露年报，公司2021年实现营业总收入9.7亿，同比增长29.2%；实现归母净利润1亿，同比增长35.8%；每股收益为0.62元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2E51B32C54466C9B46A00047DFDD6A75C_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D218C405C9AB3B9FB6B3EBBFB625E02124_w800h400.jpg" alt=""><p><strong>期间费用为6.4亿，营业成本为2亿</strong></p><p>公司2021年营业成本2亿，同比增长21.7%，低于营业收入29.2%的增速，导致毛利率上升1.3%。期间费用率为66.3%，较上年升高0.7个百分点。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D216816C928577AA23839B36D9EAE813ED_w800h400.jpg" alt=""><p><strong>本期“妇科类”营收贡献较大 </strong></p><p>从业务结构来看，“妇科类”是企业营业收入的主要来源。具体而言，“妇科类”营业收入为6.9亿，营收占比为70.8%，毛利率为78.6%。</p><img id="image15" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2C8AE5AB317F9FBA338208E04C285492D_w800h400.jpg" alt=""><img id="image17" class="autoimg" src="https://dfscdn.dfcfw.com/download/D24B7406210E18DE258BF28BF83194EC8A_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203242322033688>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)